Screener
Opko Health OPK Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|
| Proceeds from Labcorp sale | 18,392 | — |
| Net cash (used in) provided by investing activities | 13,736 | 37,694 |
| Cash flows from financing activities: | ||
| Share repurchase | (17,787) | (18,255) |
| Proceeds from the exercise of common stock options | (339) | (123) |
| Borrowings on lines of credit | 18,664 | 16,636 |
| Repayments of lines of credit | (18,721) | (19,387) |
| Settlement of convertible notes | — | (62,382) |
Item 1. Financial Statements
FAQ
- What is Opko Health's share buybacks?
- Opko Health (OPK) reported share buybacks of $13.02M in Q2 2026.
- How has Opko Health's share buybacks changed year-over-year?
- Opko Health's share buybacks decreased by 28.7% year-over-year, from $18.26M to $13.02M.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about Opko Health's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude